Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Glioma-intrinsic MAPK/ERK signaling promotes immunotherapy efficacy through T cell infiltration and interferon responses.

Nature communications·2026
Same author

Development of skull-implanted ultrasound for blood-brain barrier opening and drug delivery in neuro-oncology.

Neuro-oncology advances·2026
Same author

Phase 1 evaluation of patients with newly diagnosed glioblastoma treated with radiation, nivolumab, and IDO1 enzyme inhibitor BMS-986205.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Mesenchymal Stem Cell Secretome in Tendon Regeneration: Therapeutic Potential, Mechanisms of Action, and Future Perspectives.

Cells·2026
Same author

Comparisons and Contrasts in a Complete Set of Alkali Metal Cumyl Structures.

Inorganic chemistry·2026
Same author

Degenerative Gastrocnemius Muscle Changes in a Goat Tibial Ostectomy Model Persist 10 Months After Splint Removal.

Muscles (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 26, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Medulloblasoma: challenges for effective immunotherapy.

Adam M Sonabend1, Alfred T Ogden, Lisa M Maier

  • 1Department of Neurological Surgery, Neurological Institute, New York Presbyterian Columbia University, New York, NY 10032, USA. adam.sonabend@gmail.com

Journal of Neuro-Oncology
|December 17, 2011
PubMed
Summary
This summary is machine-generated.

Immunotherapy offers a promising alternative to traditional medulloblastoma treatments, potentially reducing debilitating side effects in children. Further understanding of tumor immunology is key to developing effective immunologic strategies.

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Related Experiment Videos

Last Updated: May 26, 2026

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
11:15

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells
12:52

Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells

Published on: November 28, 2015

Area of Science:

  • Pediatric Oncology
  • Immunology
  • Neuro-oncology

Background:

  • Current medulloblastoma treatments (surgery, radiation, chemotherapy) can cause severe long-term side effects, especially in children.
  • Immunotherapy presents a potential strategy to target medulloblastoma while minimizing damage to developing pediatric brains.

Purpose of the Study:

  • To review the current understanding of medulloblastoma immunology.
  • To identify factors hindering immune system recognition of medulloblastoma.
  • To discuss medulloblastoma tumor antigens and early immunotherapy clinical results.

Main Methods:

  • Literature review of tumor immunology in medulloblastoma.
  • Analysis of immune evasion mechanisms in medulloblastoma.
  • Summary of existing clinical immunotherapy data for medulloblastoma.

Main Results:

  • Medulloblastoma poses challenges for immune recognition.
  • Specific tumor antigens in medulloblastoma are being identified.
  • Early immunotherapy trials show potential but require further investigation.

Conclusions:

  • A deeper understanding of the medulloblastoma-immune system interaction is crucial.
  • Immunotherapy holds promise for improved medulloblastoma treatment with fewer side effects.
  • Further research and clinical trials are needed to optimize immunotherapy strategies for medulloblastoma patients.